Aprotinin is associated with a decrease in nitric oxide production during cardiopulmonary bypass

Surgery

Volumn 121, Issue 4, 1997, Pages 449-455

  Hill, Gary E ^a   Springall, David R ^b   Robbins, Richard A ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; NITRIC OXIDE; TRAYSOLOL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; INFLAMMATION; MALE; PRIORITY JOURNAL; TISSUE LEVEL;

EID: 0030896938     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6060(97)90316-0     Document Type: Article

References (38)

1. Kobzik LDS, Bredt CJ, Lowenstein J, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993;9:371-7.
2. Robbins RA, Hamel FG, Floreani AA, et al. Bovine bronchial epithelial cells metabolize L-arginine to L-citrulline: possible role of nitric oxide synthase. Life Sci 1993;52:909-16.
3. Kharitonov SA, Yates D, Robbins RA, et al. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994;343:133-5.
4. Hill GE, Snider S, Galbraith TA, et al. Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass. Am J Respir Crit Care Med 1995;152:1791-5.
5. Ying S, Robinson DS, Varnez V, et al. TNF-α mRNA expression in allergic inflammation. Clin Exp Allergy 1991;21:745-50.
6. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 1995;110:1658-62.
7. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
8. Ruvolo G, Greco E, Speziale G, et al. Nitric oxide formation during cardiopulmonary bypass. Ann Thorac Surg 1994;57:1055-6.
9. 2+-independent nitric oxide synthase activity in human lung after cardiopulmonary bypass. Thorax 1995;50:403-4.
10. Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996;270: G225-37.
11. Mathies G, Sherman MP, Buckberg GD, Haybron DM, Young HH, Ignarro NJ. Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am J Physiol 1992;262: H616-20.
12. Wendel HP, Heller W, Michel J, et al. Lower cardiac tropinin T levels in patients undergoing cardiopulmonary bypass and receiving high-dose aprotinin therapy indicate reduction of perioperative myocardial damage. J Thorac Cardiovasc Surg 1995; 109:1164-72.
13. Robbins RA, Springall DR, Warren JB, et al. Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 1994;198:835-43.
14. Archer SA. Measurement of nitric oxide in biological models. FASEB J 1993;7:349-60.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
16. Xie QW, Cho HJ, Calaycay J, et al. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992;256:225-8.
17. Nakayama DK, Geller DA, Lowenstein CJ, et al. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am J Respir Cell Mol Biol 1992;7:471-6.
18. Szabó C, Wu CC, Gross SS, Thiemermann C, Vane JR. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur J Pharmacol 1993;250:157-60.
19. Finkel MS, Oddis CV, Jacob TD, et al. Negative inotropic effects of cytokine on the heart mediated by nitric oxide. Science 1992;257:387-9.
20. Boughton-Smith NK, Evans SM, Laszlo F, et al. The induction of nitric oxide synthase and intestinal vascular permeability by endotoxin in the rat. Br J Pharmacol 1993;110:1189-95.
21. Kuo HP, Liu S, Barnes PJ. The effect of endogenous nitric oxide on neurogenic plasma exudation in guinea pig airways. Eur J Pharmacol 1992;221:177-82.
22. Berisha HI, Pakbaz H, Absood A, Said SI. Nitric oxide as a mediator of oxidant lung injury due to paraquat. Proc Natl Acad Sci USA 1994;91:1-5.
23. Walter R, Schaffner A, Schoedon G. Differential regulation of constitutive and inducible nitric oxide production by inflammatory stimuli in murine endothelial cells. Biochem Biophys Res Commun 1994;202:450-5.
24. Gerlach H, Rossaint R, Pappert D, et al. Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx. Lancet 1994; 343:518-9.
25. Persson MG, Zetterstrom O, Agrenius V, et al. Single breath nitric oxide measurements in asthmatic patients and smokers. Lancet 1994;343:146-7.
26. Massaro AF, Mehta S, Lilly CM, Kobzik L, Reilly JJ, Drazen JM. Elevated nitric oxide concentrations in isolated lower airway gas of asthmatic subjects. Am J Respir Crit Care Med 1996;153: 1510-4.
27. Persson MG, Wiklund NP, Gustafsson LE. Endogenous nitric oxide in single exhalations and the change during exercise. Am Rev Respir Dis 1993;148:1210-4.
28. Macnaughton PD, Braude S, Hunter DN, et al. Changes in lung function and pulmonary capillary permeability after cardiopulmonary bypass. Crit Care Med 1992;20:1289-94.
29. Depre C, Vanoverschelde J, Goudemant J, et al. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 1995;92:1911-8.
30. Persson MG, Lonngvist PA, Gustafsson LE. Positive end-expiratory pressure ventilation elicits increases in endogenously formed nitric oxide as detected in air exhaled by rabbits. Anesthesiology 1995;82:969-74.
31. Wachtfogel YT, Kucich U, Hack CE, et al. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. J Thorac Cardiovasc Surg 1993; 106:1-9.
32. McMichan JC, Rosengarten DS, Philipp E. Prophylaxis of posttraumatic pulmonary insufficiency by protease-inhibitor therapy with aprotinin: a clinical study. Circ Shock 1982;9:107-16.
33. Svartholm E, Haglund U, Ljungberg J, Hedner U. Influence of aprotinin, a protease inhibitor, on porcine E. Coli shock. Acta Chir Scand 1989;155:7-13.
34. Hunyadi J, Kenderessy AS, Duda E, et al. Platelet-activating factor antagonists (BN 52021 and BN 50730) inhibit tumor necrosis factor-alpha-mediated cytotoxicity on murine L929 tumor cells. Mol Immunol 1993;30:517-9.
35. Radomski MW, Palmer RM, Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci USA 1990;87:10043-9.
36. Kim H, Lee HS, Chang KT, et al. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-κβ. J Immunol 1995;154: 4741-8.
37. Xie QW, Kashiwabara Y, Nathan C. Role of transcription factor NF-κβ/Rel in induction of nitric oxide synthase. J Biol Chem 1994;269:4705-8.
38. Steinberg JB, Kapelanski DP, Olson JD, et al. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-16.